Your browser doesn't support javascript.
loading
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study.
Mills, Anthony; Arribas, Jose R; Andrade-Villanueva, Jaime; DiPerri, Giovanni; Van Lunzen, Jan; Koenig, Ellen; Elion, Richard; Cavassini, Matthias; Madruga, Jose Valdez; Brunetta, Jason; Shamblaw, David; DeJesus, Edwin; Orkin, Chloe; Wohl, David A; Brar, Indira; Stephens, Jeffrey L; Girard, Pierre-Marie; Huhn, Gregory; Plummer, Andrew; Liu, Ya-Pei; Cheng, Andrew K; McCallister, Scott.
Afiliação
  • Mills A; Southern California Men's Medical Group, Los Angeles, CA, USA.
  • Arribas JR; Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
  • Andrade-Villanueva J; Hospital Civil de Guadalajara CUCS, Universidad de Guadalajara, Guadalajara, Jal, Mexico.
  • DiPerri G; University Hospital Amadeo De Savoia, Turin, Italy.
  • Van Lunzen J; University Medical Center, Hamburg Eppendorf Infectious Diseases Unit, Hamburg, Germany.
  • Koenig E; Instituto Dominicano de Estudios Virologicos JDEZ, Santo Domingo, Dominican Republic.
  • Elion R; George Washington University School of Medicine, Washington, DC, USA.
  • Cavassini M; Infectious Disease Service, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
  • Madruga JV; Centro de Referenda e Treinamento Em DSTIAIDS, São Paulo, Brazil.
  • Brunetta J; University of Toronto, Toronto, ON, Canada.
  • Shamblaw D; La Playa Medical Group, San Diego, CA, USA.
  • DeJesus E; Orlando Immunology Center, Orlando, FL, USA.
  • Orkin C; Barts and the London NHS Trust, London, UK.
  • Wohl DA; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Brar I; Henry Ford Health System, Detroit, MI, USA.
  • Stephens JL; Mercer University School of Medicine, Macon, GA, USA.
  • Girard PM; Infectious Diseases Department, Hopital Saint Antoine, Sorbonne Universites, Univ Paris and INSERM, Paris, France.
  • Huhn G; Ruth M Rothstein Core Center, Cook County Hospital, Chicago, IL, USA.
  • Plummer A; Gilead Sciences, Foster City, CA, USA.
  • Liu YP; Gilead Sciences, Foster City, CA, USA.
  • Cheng AK; Gilead Sciences, Foster City, CA, USA.
  • McCallister S; Gilead Sciences, Foster City, CA, USA. Electronic address: scott.mccallister@gilead.com.
Lancet Infect Dis ; 16(1): 43-52, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26538525
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenina / Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Tenofovir Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenina / Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Tenofovir Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article